BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21624661)

  • 21. Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein expression in an immortalized amygdalar neuronal cell line.
    Mulchahey JJ; Regmi A; Sheriff S; Balasubramaniam A; Kasckow JW
    Endocrinology; 1999 Jan; 140(1):251-9. PubMed ID: 9886832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptors.
    Zhang G; Huang N; Li YW; Qi X; Marshall AP; Yan XX; Hill G; Rominger C; Prakash SR; Bakthavatchalam R; Rominger DH; Gilligan PJ; Zaczek R
    J Pharmacol Exp Ther; 2003 Apr; 305(1):57-69. PubMed ID: 12649353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells.
    Iredale PA; Terwilliger R; Widnell KL; Nestler EJ; Duman RS
    Mol Pharmacol; 1996 Nov; 50(5):1103-10. PubMed ID: 8913341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion.
    O'Malley D; Cryan JF; Dinan TG
    Brain Behav Immun; 2013 May; 30():115-24. PubMed ID: 23369733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF.
    Potter E; Behan DP; Linton EA; Lowry PJ; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 1992 May; 89(9):4192-6. PubMed ID: 1315056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked immunoabsorbant assay.
    Behan DP; Khongsaly O; Liu XJ; Ling N; Goland R; Nasman B; Olsson T; De Souza EB
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2579-86. PubMed ID: 8675581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension.
    Petraglia F; Florio P; Benedetto C; Gallo C; Woods RJ; Genazzani AR; Lowry PJ
    J Clin Endocrinol Metab; 1996 Feb; 81(2):852-6. PubMed ID: 8636316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells.
    Behan DP; Maciejewski D; Chalmers D; De Souza EB
    Brain Res; 1995 Nov; 698(1-2):259-64. PubMed ID: 8581494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a sheep brain corticotropin releasing factor binding protein.
    Behan DP; Cepoi D; Fischer WH; Park M; Sutton S; Lowry PJ; Vale WW
    Brain Res; 1996 Feb; 709(2):265-74. PubMed ID: 8833763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublethal hypoxia up-regulates corticotropin releasing factor receptor type 1 in fetal hippocampal neurons.
    Wang W; Ross GM; Riopelle RJ; Dow KE
    Neuroreport; 2000 Sep; 11(14):3123-6. PubMed ID: 11043535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of corticotropin-releasing factor-binding protein expression in amygdalar neuronal cultures.
    Kasckow JW; Regmi A; Seasholtz AF; Mulchahey JJ
    J Neuroendocrinol; 1999 Dec; 11(12):959-66. PubMed ID: 10583731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons.
    Ungless MA; Singh V; Crowder TL; Yaka R; Ron D; Bonci A
    Neuron; 2003 Jul; 39(3):401-7. PubMed ID: 12895416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cleavage of recombinant human corticotropin-releasing factor (CRF)-binding protein produces a 27-kilodalton fragment capable of binding CRF.
    Woods RJ; Kemp CF; David J; Sumner IG; Lowry PJ
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2788-94. PubMed ID: 10443681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of magnesium sulfate on the placental corticotropin-releasing factor (CRF) and CRF binding protein mRNA expression in perfused human placental cotyledon.
    Kropach N; Holtzman D; Vitner D; Bar J; Chen A; Kovo M
    J Matern Fetal Neonatal Med; 2016; 29(3):376-9. PubMed ID: 25655525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating "free' CRF levels in human brain.
    Behan DP; Khongsaly O; Ling N; De Souza EB
    Brain Res; 1996 Jul; 725(2):263-7. PubMed ID: 8836534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology and biology of corticotropin-releasing factor (CRF) receptors.
    Eckart K; Jahn O; Radulovic J; Radulovic M; Blank T; Stiedl O; Brauns O; Tezval H; Zeyda T; Spiess J
    Recept Channels; 2002; 8(3-4):163-77. PubMed ID: 12529934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain.
    Behan DP; Khongsaly O; Owens MJ; Chung HD; Nemeroff CB; De Souza EB
    J Neurochem; 1997 May; 68(5):2053-60. PubMed ID: 9109532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depolarization-induced release of corticotropin-releasing factor (CRF) in primary neuronal cultures of the amygdala.
    Cratty MS; Birkle DL
    Neuropeptides; 1994 Feb; 26(2):113-21. PubMed ID: 8170521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors.
    Heinrichs SC; Vale EA; Lapsansky J; Behan DP; McClure LV; Ling N; De Souza EB; Schulteis G
    Peptides; 1997; 18(5):711-6. PubMed ID: 9213365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.